文献速递生殖医学妇科

改善子宫内膜异位症患者IVF结局的新治疗靶点:综述与未来展望

Novel therapeutic targets to improve IVF outcomes in endometriosis patients: a review and future prospects.
PubMed 文献 · Hum Reprod Update · 2021-01-01

本文综述了子宫内膜异位症导致不孕的病理机制及改善IVF结局的治疗选择。检索1992年至2020年9月PubMed文献,纳入123篇。卵母细胞类固醇生成、氧化应激、细胞周期调控异常及炎症、血管生成受损可能共同导致IVF结局不佳;抗炎和抗氧化补充可能改善卵母细胞质量与妊娠率。

要点

  • 子宫内膜异位症患者卵母细胞存在类固醇代谢、氧化应激和细胞周期调控异常。
  • 颗粒细胞凋亡增加和细胞周期改变可能影响卵泡发生及胚胎质量。
  • 抗炎药物和抗氧化补充可能改善卵母细胞质量和临床妊娠率。

核心结论

  • 子宫内膜异位症相关不孕由卵母细胞多种分子机制异常共同导致,单一模型不足以描述。
  • 靶向类固醇生成、氧化应激、细胞周期、炎症和血管生成的治疗可能改善IVF结局。

研究设计与样本

  • 综述,检索PubMed数据库1992年至2020年9月发表的人类和动物研究。
  • 共纳入123篇文献。

主要发现

  • 卵母细胞单细胞RNA测序发现类固醇代谢和生物合成、氧化应激反应及细胞周期调控机制失调。
  • 卵泡微环境氧化应激增加可诱导卵母细胞细胞周期失调、卵母细胞质量差和不孕。
  • 子宫内膜异位症中颗粒细胞凋亡增加且细胞周期改变,可能不利影响卵泡发生、卵母细胞和胚胎质量及IVF结局。
  • 子宫内膜异位症与炎症损伤和血管生成受损相关,可能直接与不良IVF结局相关。

关键数值与推荐

  • GnRH类似物、孕激素和芳香化酶抑制剂未改善子宫内膜异位症相关不孕。
  • 抗炎药物和抗氧化补充可能改善子宫内膜异位症患者的卵母细胞质量、着床率和临床妊娠率。

临床怎么用

  • 对子宫内膜异位症不孕患者,可考虑抗炎和抗氧化补充作为改善IVF结局的潜在辅助治疗。
  • GnRH类似物、孕激素和芳香化酶抑制剂不推荐用于改善子宫内膜异位症相关不孕的IVF结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with endometriosis often experience infertility and have poor IVF outcomes, with low fertilization and pregnancy rates. Although many theories have tried to explain the mechanisms underlying infertility in these patients, none of them is conclusive. OBJECTIVE AND RATIONALE: In this review, we discuss the pathologic mechanisms through which endometriosis likely leads to infertility along with the therapeutic options used to date to treat endometriosis-related infertility and, thereby, to improve IVF outcomes in patients with endometriosis. SEARCH METHODS: We performed a comprehensive literature search of clinical outcomes in endometriosis and the molecular mechanisms contributing to oocyte quality using the PubMed database to identify human and animal studies published from 1992 until September 2020. In total, 123 manuscripts were included. OUTCOMES: While some theories propose that endometriosis patients may have fertility problems as a result of decreased endometrial receptivity, others reinforce the idea that infertility could be associated with oocyte alterations and lower implantation rates. Single-cell RNA sequencing of oocytes from patients with endometriosis has identified dysregulated mechanisms involved in steroid metabolism and biosynthesis, response to oxidative stress and cell cycle regulation. Dysregulation of these mechanisms could result in the poor IVF outcomes observed in patients with endometriosis. Further, impaired steroidogenesis may directly affect oocyte and embryo quality. Increased oxidative stress in patients with endometriosis also has a detrimental effect on the follicular microenvironment, inducing cell cycle dysregulation in oocytes, poor oocyte quality, and infertility. Moreover, granulosa cells in the context of endometriosis undergo increased apoptosis and have an altered cell cycle that could adversely affect folliculogenesis, oocyte and embryo quality, and IVF outcomes. Endometriosis is also associated with inflammatory damage and impaired angiogenesis, which could be directly correlated with poor IVF outcomes. While therapeutic options using GnRH analogues, progestins and aromatase inhibitors do not improve endometriosis-related infertility, anti-inflammatory agents and antioxidant supplementation could improve oocyte quality as well as implantation and clinical pregnancy rates in patients with endometriosis. WIDER IMPLICATIONS: Endometriosis is a heterogeneous disease whose pathogenesis is complex and could affect fertility by altering a collection of molecular mechanisms in oocytes. Thus, a single model is not sufficient to describe endometriosis-related infertility. Dysregulation of steroidogenesis, oxidative stress, cell cycle progression, inflammation and angiogenesis in the follicular environment and oocytes in individuals with endometriosis are all possible contributors to endometriosis-related infertility. Therefore, treatments targeting these mechanisms could be therapeutic alternatives to improve IVF outcomes for these patients.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Corachán A, Pellicer N, Pellicer A, et al. Novel therapeutic targets to improve IVF outcomes in endometriosis patients: a review and future prospects. Hum Reprod Update. 2021. PMID: 33930149. doi:10.1093/humupd/dmab014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。